Skip to main content
Caplight Logo









AUTOTAC Bio

AUTOTAC Bio

Private
SeoulHealthcare & Life Scienceshttp://autotacbio.com/

Last Round

Series B

Mar 1, 2020

Total Funding Raised

$20.8M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

AUTOTAC Bio is a biotechnology company that develops protein target decomposition therapeutics using its proprietary autophagy-targeting chimera (AUTOTAC) platform technology.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

targeted protein degradationTPDautophagy-targeting chimeraAUTOTACdrug discovery platformundruggable targetsbifunctional moleculeschemical biologyprotein degraderPROTAConcology drug developmentneurodegenerative diseasebiotech licensingsmall-molecule therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AUTOTAC Bio Comparables

Compare AUTOTAC Bio with similar companies based on industry and business-model similarity.

AUTOTAC Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Automera
89%
PAQ Therapeutics
85%
Amphista Therapeutics
83%

AUTOTAC Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 1, 2020
Series AJun 1, 2019

AUTOTAC Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 153% MoM, reaching 1.4K.

  • May 2, 2025

    Monthly visitors grew 110% MoM, reaching 998.

AUTOTAC Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AUTOTAC Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AUTOTAC Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range3
Year Founded2018
Last FundingMar 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?